Histopathology

Scaling and selling a tissue diagnostics startup: Q&A with Dr Thomas Grogan (Part 2)

Scaling and selling a tissue diagnostics startup: Q&A with Dr Thomas Grogan (Part 2)

After launching Ventana Medical Systems as a spinout from the University of Arizona, Dr Thomas Grogan played a central role in building the company from a scrappy startup into a leading provider of automated instruments for tissue biopsies and cancer diagnostics. In the second instalment of this three-part series on Dr Grogan’s life and career, […]

Scaling and selling a tissue diagnostics startup: Q&A with Dr Thomas Grogan (Part 2) Read More »

The founding of Ventana Medical Systems: Q&A with Dr Thomas Grogan (Part 1)

The founding of Ventana Medical Systems: Q&A with Dr Thomas Grogan (Part 1)

As the founder of Ventana Medical Systems, a medical technology firm that pioneered the use of automation technologies for tissue diagnostics, Dr Thomas Grogan helped drive many important advances in cancer care In the first instalment of this three-part series on Dr Grogan’s life and career, we hear about the formative experiences that led him

The founding of Ventana Medical Systems: Q&A with Dr Thomas Grogan (Part 1) Read More »

Challenges in immunohistochemistry assays explained

Screenshot of challenges in immunohistochemistry assays explained talk

Learn from Dr Lupe Manriquez, principal pathologist at Roche Tissue Diagnostics USA, as she talks about the best practices for immunohistochemistry staining in the preanalytical phase. Dr Manriquez highlights the common issues raised in preparation and staining by showing real case examples for each topic. Fixation and Slide Type [02:34] Background Staining [11:24] Specific vs.

Challenges in immunohistochemistry assays explained Read More »

The value of external quality assessment for histopathology laboratories

16 dec td webinar thumbnail 2

In this recent webinar hosted by Roche Diagnostics Asia Pacific, Dr Anne Waydelich, a scientist in the Medical & Scientific Affairs group at Roche Diagnostics EMEA LATAM, shares her experiences with external quality assessment (EQA) programmes. Dr Waydelich notes that quality controls are integral in validating results, but a meta analysis has shown that 70%

The value of external quality assessment for histopathology laboratories Read More »

Verification and validation: an overview for IHC assays

16 dec td webinar thumbnail 2

In this recent webinar hosted by Roche Diagnostics Asia Pacific, Dr Bharathi Vennapusa, a pathologist working with the Medical & Scientific Affairs field team at Roche Diagnostics USA, discusses the overarching points to consider when it comes to commercially available IHC tests. She emphasises the importance of lab quality management systems and how FDA approvals

Verification and validation: an overview for IHC assays Read More »

Digital pathology and MDTs in ophthalmology: a case study from Australia

Onco Diagnostics Webinar Series_thumbnail

In this recent webinar hosted by Roche Diagnostics Asia Pacific, Assoc. Professor Svetlana Cherepanoff, a staff specialist anatomical pathologist at St Vincent’s Hospital in Australia with research interests in ocular pathology, shares her experience using digital pathology, NGS and digital collaboration tools for better and more accurate diagnosis. Cherepanoff gives examples of how these technologies

Digital pathology and MDTs in ophthalmology: a case study from Australia Read More »

A pathologist’s perspective on triple negative breast cancer

Screenshot showing the title page of the Oncology-Pathology Perspectives in the management of advanced triple negative breast cancer patients webinar

Listen to perspectives from Professor Tan Puay Hoon, Senior Consultant Histopathologist and Chairman of the Division of Pathology at Singapore General Hospital, as she discusses triple negative breast cancer from a pathologist’s standpoint. In this recent webinar supported by the Singapore Society of Oncology, Prof Tan highlights the WHO guidelines for evaluating tumour infiltrating lymphocytes

A pathologist’s perspective on triple negative breast cancer Read More »

Remote service: keeping Australia’s molecular and histopathology labs humming

remoteserviceimage

High-quality service and support from IVD vendors is critical to the success of any molecular and histopathology lab. Remote service models, which leverage online connectivity to monitor instrument performance and deliver proactive support, are becoming increasingly popular. In Europe and North America, many clinical labs are embracing remote service models as a strategy to improve

Remote service: keeping Australia’s molecular and histopathology labs humming Read More »

COVID-19 accelerates digital pathology innovation

DP_COVID19

Amid the ongoing COVID-19 pandemic, digital pathology technologies are being used in new ways and helping to ensure continuity of care despite widespread lockdowns, travel restrictions and social distancing measures. Three exciting use cases were presented in recent webinar hosted by Roche Diagnostics Asia Pacific, with experts from Australia, India, Myanmar and Thailand sharing their

COVID-19 accelerates digital pathology innovation Read More »

Scroll to Top